#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14288	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2200	646.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1502	1502	C	767	C	716	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3767	703.3	0	.	n	.	0	T695C	SNP	695	695	T	1069	1069	C	774	C,T	547,172	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3767	703.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1711	1711	A	893	A	831	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3767	703.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2345	2345	C	822	C	756	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3767	703.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2419	2419	A	849	A	797	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26554	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3767	703.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2971	2971	C	811	C,T	754,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1882	folP	855	855	100.0	folP.l15.c4.ctg.1	1517	123.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1008	1010	AGC	203;205;206	A;G;C	188;189;188	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5022	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3465	144.6	1	SNP	p	S91F	1	.	.	271	273	TTC	625	627	TTC	174;174;173	T;T,C;C	165;164,1;164	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5022	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3465	144.6	1	SNP	p	G95N	0	.	.	283	285	GGC	637	639	GGC	166;168;171	G;G,A;C	156;155,1;159	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5022	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3465	144.6	1	SNP	p	D95G	1	.	.	283	285	GGC	637	639	GGC	166;168;171	G;G,A;C	156;155,1;159	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1498	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1363	109.3	1	SNP	p	G45D	0	.	.	133	135	GGC	542	544	GGC	168;171;173	G;G;C	153;157;158	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	774	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	938	81.5	0	.	n	.	0	A197.	DEL	197	197	A	577	577	A	159	A	147	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4732	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2986	158.0	1	SNP	p	D86N	0	.	.	256	258	GAC	633	635	GAC	166;170;169	G;A;C	155;156;157	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4732	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2986	158.0	1	SNP	p	R87I	0	.	.	259	261	CGT	636	638	CGT	168;167;170	C;G;T	156;155;155	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4732	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2986	158.0	1	SNP	p	R87W	0	.	.	259	261	CGT	636	638	CGT	168;167;170	C;G;T	156;155;155	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4732	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2986	158.0	1	SNP	p	S87R	1	.	.	259	261	CGT	636	638	CGT	168;167;170	C;G;T	156;155;155	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4732	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2986	158.0	1	SNP	p	S88P	0	.	.	262	264	TCC	639	641	TCC	171;172;175	T;C;C,T	155;157;158,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4074	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2588	156.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	208;208;208	G;G;C	184;183;180	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1247	1249	GCA	199;203;201	G;C;A	182;183;182	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1250	1252	ATC	203;202;209	A;T;C	185;182;186	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1262	1264	GTG	219;220;218	G;T;G	200;200;199	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1262	1264	GTG	219;220;218	G;T;G	200;200;199	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1766	1768	ACC	184;181;180	A;C;C	163;164;161	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1820	1822	GCG	192;191;191	G;C;G	169;157;163	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1820	1822	GCG	192;191;191	G;C;G	169;157;163	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1943	1945	AGC	172;172;176	A,G;G;C	160,1;162;164	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1952	1954	GGC	166;167;170	G;G;C	157;156;157	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4004	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2372	167.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1970	1972	CCG	139;142;143	C,G;C;G	96,4;101;103	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5364	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3204	167.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1736	1738	CCG	176;178;181	C;C;G,A	160;165;165,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2082	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1868	110.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	541	541	C	137	C	122	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2878	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1644	174.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	425	427	GAA	215;214;212	G;A;A	201;201;199	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2878	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1644	174.2	0	.	p	.	0	T119A	NONSYN	355	357	ACC	668	670	GCC	243;246;248	G,A,T;C;C,A	220,4,1;230;235,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2878	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1644	174.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	713	715	GAT	256;256;259	G,A;A;T	240,1;241;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2878	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1644	174.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	836	838	TCA	240;243;243	T;C;A	217;224;226	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2878	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1644	174.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	965	967	GTC	237;236;239	G,A;T;C,G	221,1;220;223,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2878	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1644	174.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1295	1297	GCA	234;237;239	G;C;A	218;220;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2878	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1644	174.2	1	SNP	p	G120K	1	.	.	358	360	AAG	671	673	AAG	243;242;241	A;A;G	230;229;229	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2878	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1644	174.2	1	SNP	p	A121D	1	.	.	361	363	GAC	674	676	GAC	236;234;237	G;A;C	224;220;227	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2878	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1644	174.2	1	SNP	p	D121N	0	.	.	361	363	GAC	674	676	GAC	236;234;237	G;A;C	224;220;227	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10966	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5206	210.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1200	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	983	121.4	1	SNP	p	V57M	1	.	.	169	171	ATG	491	493	ATG	244;244;242	A;T;G	230;230;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
